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Abstract 
Pluripotency-associated transcription factors (PATF) play significant roles during early embryogenesis and in 
embryonic stem (ES) cells, such as control of cell-cycle progression, modulation of cellular metabolism, and 
transcriptional control of differentiation-inducing factors. The review aims to describe the current 
understanding of how these PATFs contribute to the early embryo and the ES-cell phenotypes. By a selection 
of representative examples of such PATFs, their roles are described, and some interesting questions are 
presented concerning their activity in pluripotent cells which have yet to be addressed. 
Keywords: embryology; pluripotent; preimplantation development; totipotency. 
 
Resumo 
Fatores de transcrição relacionados à pluripotência (FTRP) apresentam importantes funções durante a 
embriogênese inicial e em células-tronco embrionárias (CTE), como o controle da progressão do ciclo celular, 
modulação do metabolismo celular e controle transcricional de fatores indutores de diferenciação celular. O 
objetivo da revisão foi descrever o conhecimento vigente sobre como estes FTRPs contribuem para o fenótipo 
dos embriões e CTEs. Através da seleção de exemplos representativos destes FTRPs, suas funções são descritas 
e algumas perguntas interessantes são apresentadas considerando suas atividades em células pluripotentes, mas 
que ainda não foram devidamente respondidas. 
Palavras-Chave: embriologia; pluripotente; desenvolvimento pré-implantacional; totipotência. 
 
Introduction  
Early embryogenesis in mammals can be 
defined as the period of development before 
implantation (Rossant, 2007; Cockburn and 
Rossant, 2010; Wu et al., 2017). After the process 
of fertilization and egg activation, DNA replication 
is initiated in both haploid genomes, followed by 
syngamy of pro-nuclei and the first mitotic 
division, thus forming the two-cell stage embryo 
(Rossant, 2007; Wu et al., 2017). Moreover, the 
embryo goes through several rounds of cell 
divisions, denominated cleavages, that ultimately 
lead to a progressive reduction in blastomere 
volume (Figure 1). During this period of embryonic 
development, blastomeres remain relatively similar 
in shape, and have limited adhesion among them. 
There is no transcription in the early embryo and 
its developmental coordination and timing are 
determined by maternal factors found in the egg 
(Latham, 1999; Wu et al., 2017). Therefore, such 
cleavage divisions are rather fast in timing, with 
short G1 and G2 phases during the cell cycle 
(Frankenberg et al., 2016; Wu et al., 2017). 
After a variable number of cell divisions 
(i.e., 2-cell stage in mice, 8-16 cell transition in 
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ruminants), embryos go through the embryonic 
genome activation (EGA) (Memili and First, 
2000). EGA activates the genes of the embryo that 
progressively dominate the transcriptional output 
of embryonic cells (Latham, 1999; Wu et al., 
2017). When the EGA is concluded, the embryo 
faces a period of compactation (Frankenberg et al., 
2016). At this stage, outer cells carry out a 
morphological change and acquire an epithelial-
like morphology, in contrast to the spherical shape 
of inner cells in the embryo (Cockburn and 
Rossant, 2010; Wu et al., 2017). This difference in 
blastomere morphology becomes more evident at 
the morula stage (Figure 1), alongside with 
transcriptional variations are observed in these two 
different cell types (Rossant, 2016; Wu et al., 
2017). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Developmental potential of early embryos and embryonic stem cells. Totipotency is limited to early cleavage-stage embryos 
before embryonic genome activation (EGA) (dark green). After blastocyst formation, the inner cell mass (ICM) progressively 
exits pluripotency toward the three embryonic germ layers (light green). Trophectoderm cells (TC) gradually differentiates 
into placenta-forming cell types (Orange). Alternatively, a stable pluripotency state is captured by establishment and 
propagation of ICM-derived embryonic stem (ES) cells. 
 
At a discrete portion of the embryo, liquid 
begins to accumulate, leading to blastocele 
formation. The expansion of the blastocele occurs 
in parallel to the process of cellular differentiation 
that is culminated at the blastocyst stage (Figure 1), 
with the segregation between the inner cell mass 
and trophectoderm (Rossant, 2007; Wu et al., 
2017). There are significant differences in embryo 
morphology among mammalian species 
(Frankenberg et al., 2016), although their 
functional properties remain similar.   
The process of cellular differentiation that 
was initiated during the compactation period is 
closed with the formation of the blastocyst 
(Cockburn and Rossant, 2010; Wu et al., 2017). 
The outer cells of the blastocyst make the 
trophectoderm, thus carrying an epithelial-like 
morphology and give the three-dimensional 
structure of the blastocyst. The inner cell mass 
(ICM) is composed of round cells aggregated in a 
three-dimensional structure and adhered to the 
trophectoderm. More importantly, these 
morphological changes are accompanied by 
contrasting functional and developmental potency 
abilities (Wu et al., 2017). The trophectoderm gives 
rise to all cell types that make up the placenta, 
while the ICM has the potential to form all cell 
types that make up the fetus (Cockburn and 
Rossant, 2010; Rossant, 2016).  
 
Totipotency 
The tremendous developmental capacity of 
early embryos has been the focus of intense 
experimentation since the XIX century (Tagarelli 
et al., 2004). Initial studies relied on amphibian 
embryos, which are relatively large, easy to culture 
in simple solutions, have considerable size 
compared to their mammalian counterparts, and are 
more resistant to experimental manipulation 
(Gurdon, 2006). The mechanical isolation of two 
blastomeres in a frog embryo resulted in the 
formation of two tadpoles, thus proving that such 
cells retain the capacity to give rise to the whole 
organism (Tagarelli et al., 2004). Similar 
experiments were carried out with mammalian 
embryos up to the eight-cell stage (Moore, 1968; 
Willadsen, 1981), leading to the understanding that 
this developmental potency, denominated 
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totipotency, is also retained in such embryos. Thus, 
totipotency is defined as the capacity to derive all 
cell types that make up the fetus and the placenta 
(Rossant, 2016). Remarkably, no cell type retains 
the totipotency state after the EGA. 
 
Pluripotency 
The pluripotent state is defined as the 
capacity of a cell to differentiate into all tissues of 
the three germ layers, namely endoderm, 
mesoderm, and ectoderm. Pluripotent cells display 
high nuclear to cytoplasm ratio, multiple nucleoli, 
relatively short cell cycles, among other distinctive 
features (Smith, 2001). The ICM differentiates into 
the epiblast and hypoblast, that will form the fetus 
and amniotic sac, respectively (Cockburn and 
Rossant, 2010; Rossant, 2016). The epiblast cells 
also give rise to primordial germ cells (PGC) 
(McLaren, 2000), that migrate to gonadal ridges 
and form the germ cells lineages (Barton et al., 
2016). 
The introduction of ICM pluripotent cells 
into recipient embryos demonstrates that these cells 
contribute to the formation of mots, if not all, 
tissues in the fetus (Nagy et al., 1990; Picard et al., 
1990). By using modified embryos that 
progressively contribute exclusively to placenta 
formation, the introduction of pluripotent cells 
allows the formation of viable fetuses (Nagy et al., 
1990). 
The isolation and in vitro culture of the ICM 
under defined conditions allow the establishment 
of cultures of pluripotent cells coined as embryonic 
stem (ES) cells (Evans and Kaufman, 1981; Smith, 
2001; Buehr et al., 2008; Li et al., 2008). These ES 
cells maintain a typical morphology and can be 
propagated indefinitely in culture (Smith, 2001; 
Moura, 2012). When exposed to differentiation-
inducing factors, such as growth factors and 
cytokines, they exit the pluripotent state and 
differentiate into multiple cell types both in vitro 
and in vivo (Smith, 2001). Moreover, when subject 
to appropriate differentiation cues, ES cells are 
capable of forming relatively homogeneous 
populations of discrete cell types, such as motor 
neurons or cardiomyocytes (Smith, 2001; Wernig 
et al., 2007; Ichida et al., 2014). 
The introduction of ES cells in recipient 
embryos results in the formation of fetuses with 
contribution of cells of both origins (Bradley et al., 
1984). Moreover, since ES cells are pluripotent, 
they require a recipient embryo for the placenta 
formation (Nagy et al., 1990; Eggan et al., 2002). 
Collectively, these in vivo functional assays 
demonstrate the pluripotent nature of ES cells.  
 
Unraveling the control of totipotency and 
pluripotency 
The investigation at the molecular level of 
pluripotency in early embryos holds several 
challenges, such as fast developmental kinetics, 
transcription-independent development during 
cleavage stages, cellular differentiation in a 
relatively short period, and limited stating 
biological material for experimentation 
(Hochedlinger and Jaenisch, 2006; Moura, 2012). 
Due to these factors, most investigations on 
pluripotency control relies on ES cells, thus 
contributing to a fast-paced understanding of the 
mechanism (Hochedlinger and Jaenisch, 2006; 
Moura, 2012). In humans, ES cells require different 
culture conditions compared to mouse counterparts 
to sustain pluripotency and self-renewal (Amit et 
al., 2000; Chen et al., 2015).  
The genetic ablation of a gene contributes to 
the determination of its functions since cell 
phenotype lacking the factor can be readily 
observed (Capecchi, 1989, 2005). By the 
identification of genes required for pluripotency, 
their characterization began to increase (Nichols et 
al., 1998; Niwa et al., 2000; Chambers et al., 2003; 
Dejosez et al., 2008). 
The genes required for the maintenance of 
pluripotency or that play central roles in this 
cellular state are collectively called pluripotency 
genes (Li and Belmonte, 2017). Initially, 
pluripotency genes were identified as those with 
expression restricted to pluripotent or totipotent 
cells, namely germ cells, oocytes, early embryos, 
and ES cells (Schöler et al., 1989; Chambers et al., 
2003; Mitsui et al., 2003). With the increasing 
number of pluripotency genes characterized (Heng 
et al., 2010), it became evident that few of such 
genes indeed have a pluripotency-specific gene 
expression profile. 
The number of pluripotency genes 
characterized continues to grow and thus seems to 
be relatively far from saturation (Subramanian et 
al., 2009; Zheng and Hu, 2014). Therefore, the 
mechanisms by which pluripotency genes control  
this cellular state is expected to grow in players and 
complexity in the foreseeable future. This 
understanding should contribute to better 
understanding of the mechanisms of totipotency, 
pluripotency, embryonic development, and self-
renewal of ES cells. The dissection of how each 
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pluripotency gene contributes to the pluripotency 
state has shed light on how this cellular state is  
controlled at the molecular level (Table 1).  
 
 
Table 1. Requirement of selected pluripotency-associated transcription factors in early preimplantation 
embryos and embryonic stem cells. 
Gene Required for 
Blastocyst 
Development 
Required for  
ES Pluripotency 
Organism Observations of null or 
knockdown phenotypes 
References 
C-MYC No No Mouse Redundancy with L-MYC 
and N-MYC, while sole 
ablation of C-MYC causes 
lower proliferation 
Scognamiglio et al., 2016 
DAX1 No Yes Mouse Impaired testis 
development and  
male infertility in mice 
Yu et al.., 1998;  
Niakan et al., 2006 
GLIS1 Yes Not Reported Cattle Development arrest at the 
4-cell stage in cattle 
Takahashi et al., 2015 
KLF5 No No* Mouse KLF2, KLF4, and KLF5 
redundancy in ES cells*; 
Embryonic loss before 
E6.5 in mice  
Ema et al., 2008 
NANOG No Yes Mouse NANOG-deficient ICM 
fail to generate epiblast 
Chambers et al., 2003; 
Mitsui et al., 2003 
OCT4 No#; 
Yes 
Yes Mouse, Cattle, 
Pig, and 
Human 
ICM is not pluripotent in 
the mouse# 
Nichols et al., 1998; 
Kwon et al., 2015; 
Sakurai et al., 2016; 
Fogarty et al., 2017  
RONIN No Yes Mouse Embryonic loss at E7.5  
in mice  
Dejosez et al., 2008 
SOX2 No, Yes Yes Mouse and 
Cattle 
One intact cell in a two-
cell bovine embryo rescues 
development 
Avilion et al., 2003; 
Gossis and Cibelli, 2014; 
Sakurai et al., 2016 
ZFP281 Unknown Variable** Mouse Possible confounding 
effect of knockdown assay 
or culture conditions** 
Wang et al., 2006; 
Fidalgo et al., 2011 
ZFX No No, Yes Mouse and 
Human 
Full-term development, 
but smaller, less viable  
and diminished pool  
of germ cells 
Luoh et al., 1997 
ICM: inner cell mass. E6.5-7.5: 6.5 and 7.5 embryonic days post-coitus, respectively. 
 
 
Pluripotency-Associated Transcription Factors 
Genes characterized for pluripotency control 
are predominantly composed of transcription 
factors, thus pluripotency-associated transcription 
factors (PATF) (Young, 2011; Yeo and Ng, 2013). 
These PATFs act on gene regulation, by inducing 
or silencing target genes. Several PATFs are 
required for the establishment of cellular states, 
acting as sole factors, but more frequently in an 
orchestrated manner to control. dozens or hundreds  
of  downstream  target  genes  (Boyer et  al.,  2005;  
Kim et al., 2008; Young, 2011). 
A new striking demonstration of the 
importance of pluripotency genes was 
demonstrated by the cellular reprogramming of 
mouse and human somatic cells with their ectopic 
expression (Takahashi and Yamanaka, 2006, 2016; 
Takahashi et al., 2007). These induced pluripotent 
stem (iPS) cells, closely resemble and are 
functionally similar to embryo-derived ES cells 
(Maherali et al., 2007; Okita et al., 2007; Wernig et 
al., 2007; Ichida et al., 2014). 
 
Selection of Functionally-investigated PATFs 
C-MYC 
CMYC is part of a family of transcription 
factors composed of C-MYC, N-MYC, and L-
MYC (Fagnocchi and Zippo, 2017). The C-MYC 
gene displays diverse functions in pluripotent cells, 
such as cell cycle control, cellular metabolism, 
modulation of signaling pathways, epigenetic 
control of target genes, and other transcription 
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factors, such as HOX genes (Fagnocchi and Zippo, 
2017). Both CMYC and NMYC show similar 
expression patterns during mouse preimplantation 
development and are functionally redundant for 
pluripotency (Smith et al., 2010). The expression 
of CMYC has also been analyzed in 
preimplantation embryos of ruminants species 
(Miles et al., 2012; Madeja et al., 2013; Singh et 
al., 2014; Silva et al., 2017), but its functional roles 
in such species remain to be described.  
 
Dosage-sensitive sex reversal, adrenal 
hypoplasia critical region, chromosome X, gene 
1 (DAX1)  
DAX1 (NR0B1) was detected in oocytes and 
during all embryonic development of several 
species (Clipsham et al., 2004; Stickels et al., 2015; 
Moura et al., 2017; Silva et al., 2017). The 
characterization of mice lacking DAX1 
demonstrated to be dispensable for early 
embryonic development (Table 1), implantation, 
and oogenesis (Yu et al., 1998). In contrast, male 
germ cells do not complete spermatogenesis due to 
progressive degeneration of the germinative 
testicular epithelium in mice lacking DAX1 (Yu et 
al., 1998).  
Alternatively, DAX1 contributes to cellular 
reprogramming by facilitating the reactivation of 
other pluripotency genes (Zhang et al., 2014; Lujan 
et al., 2015), although the requirement of its 
activity to maintain pluripotency remains 
controversial (Khalfallah et al., 2009; Zhang et al., 
2014). The understanding of DAX1 downstream 
targets in both pluripotent cells and during 
reprogramming may shed light on how this PATF 
play such contrasting roles.   
 
Glis family zinc finger 1 (GLIS1) 
GLIS1 was identified in a prospection of 
transcription factors that are involved in cellular 
reprogramming (Maekawa et al., 2011). Its 
expression in mice is enriched in eggs and zygotes, 
but lower in ES cells, fibroblasts, and other somatic 
cell types (Maekawa and Yamanaka, 2011). It is 
possible that GLIS1 was not previously identified 
as a pluripotency gene since its expression is quite 
similar between somatic and pluripotent cells 
(Maekawa and Yamanaka, 2011). In cattle, GLIS1 
is more abundant in eggs, embryos up to the four-
stage embryo and is barely detected at the eight-cell 
stage (Takahashi et al., 2015). The knockdown of 
GLIS1 after fertilization blocks embryonic 
development at the eight-cell stage, possibly due to 
a partial or complete block of embryonic genome 
activation (Takahashi et al., 2015). The genome-
wide binding profile of GLIS1 in ES cells may be 
informative about its roles during development and 
possibly for understanding its contribution to 
cellular reprogramming.  
 
Kruppel-Like Factor 5 (KLF5) 
KLF5 is part of the Kruppel-like family of 
transcription factors, composed of 17 members, 
with diverse activities in several biological 
processes such as cellular proliferation, 
metabolism, stress response, among others (Diakiw 
et al., 2013; Farrugia et al., 2016). KLF5 holds 
stable expression throughput embryonic 
development in mice and is required for 
maintenance of pluripotency (Ema et al., 2008; 
Parisi and Russo, 2011). The influence of KLF5 on 
mouse pluripotency depends on the regulation of 
other pluripotency genes and silencing of genes 
responsible for cellular differentiation (Parisi and 
Russo, 2011). The genes KLF2, KLF4, and KLF5 
seen to hold redundant activities in mouse ES cells 
(Jiang et al., 2008). These genes share multiple 
targeted downstream genes, particularly NANOG, 
while concomitant silencing of all three genes is 
required for loss of pluripotency in ES cells (Jiang 
et al., 2008). Further efforts trying to phenocopy 
the cellular effects of KLF members in ES cells 
(i.e., modulation of signaling pathways) should be 
instructive in understanding their roles in 
pluripotency and development.  
 
NANOG  
NANOG is another major PATF that 
controls pluripotency and is required for 
development (Mitsui et al., 2003). NANOG is a 
homeodomain protein, with a unique DNA-protein 
interaction domain and relatively low homology 
across species (Chambers et al., 2003). In the 
mouse, NANOG is expressed after embryo 
compactation and remains restricted to ICM-
forming cells (Chambers et al., 2003). The 
expression of NANOG in livestock is found 
throughout preimplantation development (He et al., 
2006; Gossis and Cibelli, 2014). NANOG is 
required for both ES cell pluripotency in vitro and 
in vivo (Chambers et al., 2003; Mitsui et al., 2003). 
NANOG shares hundreds of target genes with 
OCT4 and SOX2 (Boyer et al., 2005; Loh et al., 
2006). However, NANOG should be functionally 
investigated in greater detail during early 
development and among species. 
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Octamer-binding transcription factor 4 (OCT4) 
The OCT4 gene was the first pluripotency-
associated transcription factor described in early 
embryos (Schöler et al., 1989, 1990; Rosner et al., 
1990) and also the first functionally investigated 
(Nichols et al., 1998; Niwa et al., 2000; Zeineddine 
et al., 2014). OCT4 displays expression restricted 
to germ cells, oocytes, early preimplantation 
embryos, and ES cells. The silencing of OCT4 
causes the formation of blastocysts lacking a 
pluripotent ICM (Table 1), thus with 
developmental potential restricted to trophoblast-
derived lineages (Nichols et al., 1998). Curiously, 
trophoblast cells require paracrine signaling from 
pluripotent cells, to retain their bona fide state and 
viability (Nichols et al., 1998; Le Bin et al., 2014). 
Although cleavage-stage embryonic development 
occurs without OCT4, the segregation between 
epiblast and primitive endoderm is extinguished in 
ICM cells lacking OCT4 (Le Bin et al., 2014).  
The investigation of the OCT4 function at 
the genomic level has substantially contributed to 
the understanding of how OCT4 acts upon the 
control of pluripotency (Boyer et al., 2005; Loh et 
al., 2006; Zeineddine et al., 2014). OCT4 forms 
heterodimers with SOX2 and other TFs (Rizzino, 
2013), to regulate hundreds of downstream target 
genes in mouse and human ES cells (Boyer et al., 
2005; Loh et al., 2006). The OCT4-SOX2 complex 
activates other pluripotency genes, controls several 
signaling pathways, and silences differentiation-
inducing developmental regulators (Boyer et al., 
2005; Rizzino, 2013; Zeineddine et al., 2014). The 
investigation of OCT4 at the genome-wide level 
across species should shed light on how this PATF 
master regulator evolved to contribute to the 
control of pluripotency.   
 
RONIN (THAP11) 
RONIN was identified as a factor that 
physically interacts with Caspase 3 in mouse ES 
cells during differentiation (Dejosez et al., 2008). It 
was previously demonstrated that NANOG protein 
cleavage by Caspase 3 was a mechanism for 
induction of ES cell differentiation (Fujita et al., 
2008). In an investigation of proteins that bind to 
NANOG in ES cells, RONIN (THAP11) was 
identified as a candidate factor. Curiously, RONIN 
was dispensable for early embryogenesis, and its 
target genes were not shared by the core 
transcriptional circuitry established by OCT4, 
SOX2, and NANOG (Boyer et al., 2005; Dejosez 
et al., 2008). This fact suggested that RONIN 
contributes differently than these other PATFs to 
the control of pluripotency. A follow-up analysis 
showed that RONIN participates in the control of 
cellular processes such as transcription initiation, 
alternative splicing, and cellular metabolism 
(Dejosez et al., 2010). The association of RONIN 
to HCF-1 contributes to ES cells self-renewal and 
pluripotency by elevating the expression of genes 
responsible for protein synthesis, and energy 
production (Dejosez et al., 2010). The molecular 
circuitry formed by RONIN needs to be further 
explored to elucidate better how this PATF 
contribute to pluripotency in embryos and ES cells.  
 
SOX2 
SOX2 is one of the twenty members of the 
Sry-related HMG box family of transcription 
factors with various roles during development 
(Avilion et al., 2003). SOX2 forms a heterodimer 
with OCT4 and binds to motifs near each other in 
the genome (Boyer et al., 2005; Rizzino, 2013; 
Zeineddine et al., 2014). The SOX2 mRNA and 
protein are detected throughout preimplantation 
development in several mammalian species and 
becomes restarted to the ICM (Avilion et al., 2003; 
Goissis and Cibelli, 2014), but its requirement for 
development was demonstrated in cattle (Goissis 
and Cibelli, 2014; Sakurai et al., 2016). The 
unraveling of SOX2 requirement during 
preimplantation development of certain species 
should be an attractive area of investigation. 
  
Zinc Finger Protein 281 (ZFP281)  
ZFP281 (Znf281) was identified as a 
pluripotency gene due to its differential expression 
between mouse somatic and ES cells (Wang et al., 
2006). More recently, its expression has been 
described in early embryos of ruminant species 
(Moura et al., 2017; Silva et al., 2017). The 
requirement for ZFP281 to maintain pluripotency 
remains conflicting (Table 1), possibly due to 
differences in experimental conditions such as gene 
silencing approach and ES cell culture conditions 
(Wang et al., 2006; Fidalgo et al., 2011). ZFP281 
forms complexes with NANOG, OCT4, and SOX2 
in ES cells (Wang et al., 2006, 2008), thus 
suggesting to be a downstream factor of the OCT4-
SOX2-NANOG circuitry. Moreover, ZFP281 
controls several downstream target genes with the 
above ciruitry, although its primary role is their 
expression fine-tuning, including other 
pluripotency genes (Wang et al., 2008; Fidalgo et 
al., 2011). Due to this function on other 
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pluripotency genes, ZFP281 reduces the efficiency 
of cellular reprogramming by defined factors 
through blocking NANOG reactivation (Fidalgo et 
al., 2012).  
 
Zinc Finger Protein, X-Linked (ZFX) 
The temporal expression of ZFX during 
embryonic development has been described in 
several species and was one of the first X-linked 
genes characterized (Bernardi et al., 1996; Yu et 
al., 1998; Peippo et al., 2002). ZFX has a homolog 
on the Y chromosome, denominated ZFY, with 
stable expression throughout the preimplantation 
development of male embryos (Bernardi et al., 
1996). Moreover, embryos lacking ZFX can reach 
the blastocyst stage and survive until implantation 
(Luoh et al., 1997; Galan-Caridad et al., 2007). In 
contrast, it was demonstrated that ZFX is necessary 
for both mouse and human pluripotency (Galan-
Caridad et al., 2007; Harel et al., 2012). It remains 
an open question why ES cells are dependent on 
ZFX in contrast to early embryos.  
 
Final Considerations 
Pluripotency has been a focus of intense 
investigation over the past two decades. 
Considerable progress has been made toward 
understanding how a subset of genes, namely 
pluripotency-associated transcription factors, 
contribute to the establishment and maintenance of 
such a cellular state. Due to the intrinsic limitations 
posed by early preimplantation embryos for 
experimentation and likely culture-induced effects 
of ES cell propagation, future investigations should 
continue to be based on these two systems as 
converging approaches. Investigations in livestock 
and other species (aside from mice and humans) 
should also shed light on how pluripotency is 
controlled at the molecular level across mammalian 
species.  
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